Name: EnterNext welcomes Oncodesign on Alternext in Paris
Uploaded: 2014-04-02T09:52:11+0200
Description: Philippe Genne, CEO of Oncodesign, opens the European trading day in Paris. Oncodesign specializes in the research and development of drugs for the treatment of cancer. The group provides preclinical pharmacological evaluation services in the oncology field.

Search Contact

This page is available in multiple languages

Select Language

Back

02/04/2014

Philippe Genne, CEO of Oncodesign, opens the European trading day in Paris.

Oncodesign specializes in the research and development of drugs for the treatment of cancer. The group provides preclinical pharmacological evaluation services in the oncology field.